Purpose: Fragmented ownership of diagnostic gene patents has the potential to create an “anticommons” in the area of genomic diagnostics, making it difficult and expensive to assemble the patent ...

A unanimous U.S. Supreme Court ruling Monday backed away from a decades-old legal test that high-tech firms argue has sparked an abundance of obvious patents. In a hotly anticipated decision that ...

Counsel at Novartis and other pharma firms explain how the ever-changing standard for patent eligibility in the US has frustrated innovation by narrowing the scope of patentable subject matter ...

In May, the Federal Circuit issued its decision in 'LKQ v. GM Global Technology Operations', which marks a significant shift away from the prior and more rigid 'Rosen-Durling test', toward a more ...

Rulings in patent ownership disputes have provided useful guidance on how China’s courts interpret the determination of rights, explains Ruo Cao and Mengxuan Zhang of China Patent Agent (HK) Ltd. With ...

An American firm’s new European patent on a screening test for a genetic mutation that causes breast cancer has created an uproar among geneticists in Israel and Europe, who say the patent raises ...

LKQ Corp. v. GM Global Technology Operations LLC has brought attention to the ongoing debate surrounding design patent law, particularly with respect to the Rosen-Durling test for design patent ...

“U.S. courts have made clear that mere plausibility is not the test for enablement, finding that patentees could otherwise obtain patent rights to purported inventions consisting of little more than ...